Literature DB >> 6417473

Inhibition of microbial IgA proteases by human secretory IgA and serum.

J V Gilbert, A G Plaut, B Longmaid, M E Lamm.   

Abstract

Microbial IgA proteases cleave human serum IgA1 immunoglobulin, but human secretory IgA is resistant to hydrolysis. We have found this resistance to be due to an inhibition of protease activity that is mediated by the Fab region of secretory IgA. The IgA proteases of the genus Neisseria are more sensitive to inhibition than is the protease of Streptococcus sanguis. There is also a serum inhibitor of Neisseria proteases that co-chromatographs with IgG. Monoclonal (myeloma) human IgG proteins and plasma protease inhibitors such as alpha-1-antitrypsin and alpha-2-macroglobulin do not inhibit. Human sera do not contain inhibitor to S. sanguis protease activity. We conclude that microbial IgA proteases are subject to inhibition by IgA in secretions and IgG in serum, and this activity is most consistent with being an anti-enzyme antibody. The insensitivity of S. sanguis IgA protease to inhibition is unexplained but provides further evidence that the IgA proteases are structurally diverse.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417473     DOI: 10.1016/0161-5890(83)90045-7

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  22 in total

1.  Inhibition of Prevotella and Capnocytophaga immunoglobulin A1 proteases by human serum.

Authors:  E V Frandsen; M Kjeldsen; M Kilian
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

Review 2.  Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.

Authors:  Q Zhang; A Finn
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

3.  Actions of three clostridial IgA proteases on distinct forms of immunoglobulin A molecules.

Authors:  O H Hashim; H Hassan
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

4.  Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases.

Authors:  B W Senior; J I Dunlop; M R Batten; M Kilian; J M Woof
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection.

Authors:  Per Akesson; Linnea Moritz; Mikael Truedsson; Bertil Christensson; Ulrich von Pawel-Rammingen
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  Detection of immunoglobulin A1 protease-induced Fab alpha fragments on dental plaque bacteria.

Authors:  T Ahl; J Reinholdt
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

Review 7.  Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases.

Authors:  M Kilian; J Mestecky; M W Russell
Journal:  Microbiol Rev       Date:  1988-06

8.  Antigenic relationships among immunoglobulin A1 proteases from Haemophilus, Neisseria, and Streptococcus species.

Authors:  H Lomholt; M Kilian
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Antigenic variation of immunoglobulin A1 proteases among sequential isolates of Haemophilus influenzae from healthy children and patients with chronic obstructive pulmonary disease.

Authors:  H Lomholt; L van Alphen; M Kilian
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

10.  Synthetic peptide substrates for the immunoglobulin A1 protease from Neisseria gonorrhoeae (type 2).

Authors:  S G Wood; J Burton
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.